© 2020, Partners Pharma Theme.
All right reserved.
In stock
DIART®
€22.99
DIART is a medical device which represents an intra-articular hyaluronic acid injection. This enables better joint mobility in patients with osteoarthritis, reduces joint inflammation and pain and further disease progression is slowed down.
-
Description
-
Additional information
-
Reviews (0)
DIART®
Informacion i pergjitshem i medikamentit
- By creating a highly elastic layer that surrounds the joint, it reduces friction when making movements
- Improves the synovial fluid function
- Topically reduces inflammation
- Reduced pain sensation and decreased need for analgesics
- Better joint mobility
- Hyaluronic acid is of optimum pH and it is not of animal origin which prevents the allergic reactions
- DIART contains the pre-filled disposable syringe with 36 mg of hyaluronic acid and sodium succinate.
- Hyaluronic acid is a building element that creates a highly elastic layer on the joint surface In this way, it restores cartilage elasticity and has a positive effect on the restoration of synovial fluid function. In addition, large hyaluronic acid molecules reduce inflammation locally, reducing pain and increasing joint mobility.
- Hyaluronic acid in this product is:
- of synthetic origin, which prevents allergic reactions
- of high-molecular-weight, about 3.000 kDa in size
- purified
- of optimum pH
- Sodium-succinate is important for patients with osteoarthritis because it acts as a potent antioxidant and influences the reduction in production of certain types of molecules which are directly involved in the development of osteoarthritis.
- In osteoarthritis grades 1-3
- Post-traumatically
- After arthroscopy
| Usage | DIART should be administered by healthcare professionals only who are trained for injecting it into joints and it should be administered only in the synovial space. |
|---|
There are no reviews yet.